StockMacro
Company, fund or insider

Help

Menu

Bath & Body Works

$18.66 +5.2% in 6 monthsMarket cap $3.8B

BBWI on XNYS, Retail, Bath & Body Works, Inc., job postings

Measures activity, not value. Not investment advice.

Sales fell 2.2% over 12 months but profit rose 6.2% to $742M while news ran 16 times normal.

  • BadLatest quarter revenue down 1.1% against a year earlier
  • WatchCapital spending down 30% to $57M in the latest quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 31 Oct 2026

Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 4% of sales from international markets in fiscal 2025. For fiscal 2025, 77% of sales stemmed from the brick-and-mortar network of more than 1,900 retail stores, similar to 2024 levels, as consumer shopping patterns remained normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like lip.

Industry
Retail-retail stores, nec (Retail)
Employees
60,735
Website
bbwinc.com
Listed
NYSE, US
Last results
19 Nov 2026
Next results
expected around 3 Mar 2027 (an estimate: a year ago it reported on 4 Mar 2026)
Revenue and net income per quarter. Quarter to 31 Oct 2026: revenue $1.6B, net income $38.0M.
Quarter to 29 Jan 2022: revenue $3.0B, net income $594.0MQuarter to 29 Jan 2022: revenue $3.0B, net income $594.0MQuarter to 30 Apr 2022: revenue $1.4B, net income $155.0MQuarter to 30 Apr 2022: revenue $1.4B, net income $155.0MQuarter to 30 Jul 2022: revenue $1.6B, net income $120.0MQuarter to 30 Jul 2022: revenue $1.6B, net income $120.0MQuarter to 29 Oct 2022: revenue $1.6B, net income $91.0MQuarter to 29 Oct 2022: revenue $1.6B, net income $91.0MQuarter to 28 Jan 2023: revenue $2.9B, net income $434.0MQuarter to 28 Jan 2023: revenue $2.9B, net income $434.0MQuarter to 29 Apr 2023: revenue $1.4B, net income $81.0MQuarter to 29 Apr 2023: revenue $1.4B, net income $81.0MQuarter to 29 Jul 2023: revenue $1.6B, net income $99.0MQuarter to 29 Jul 2023: revenue $1.6B, net income $99.0MQuarter to 28 Oct 2023: revenue $1.6B, net income $119.0MQuarter to 28 Oct 2023: revenue $1.6B, net income $119.0MQuarter to 3 Feb 2024: revenue $2.9B, net income $579.0MQuarter to 3 Feb 2024: revenue $2.9B, net income $579.0MQuarter to 4 May 2024: revenue $1.4B, net income $87.0MQuarter to 4 May 2024: revenue $1.4B, net income $87.0MQuarter to 3 Aug 2024: revenue $1.5B, net income $152.0MQuarter to 3 Aug 2024: revenue $1.5B, net income $152.0MQuarter to 2 Nov 2024: revenue $1.6B, net income $106.0MQuarter to 2 Nov 2024: revenue $1.6B, net income $106.0MQuarter to 1 Feb 2025: revenue $2.8B, net income $453.0MQuarter to 1 Feb 2025: revenue $2.8B, net income $453.0MQuarter to 3 May 2025: revenue $1.4B, net income $105.0MQuarter to 3 May 2025: revenue $1.4B, net income $105.0MQuarter to 2 Aug 2025: revenue $1.5B, net income $64.0MQuarter to 2 Aug 2025: revenue $1.5B, net income $64.0MQuarter to 1 Nov 2025: revenue $1.6B, net income $77.0MQuarter to 1 Nov 2025: revenue $1.6B, net income $77.0MQuarter to 31 Jan 2026: revenue $2.7B, net income $403.0MQuarter to 31 Jan 2026: revenue $2.7B, net income $403.0MQuarter to 2 May 2026: revenue $1.4B, net income $183.0MQuarter to 2 May 2026: revenue $1.4B, net income $183.0MQuarter to 1 Aug 2026: revenue $1.5B, net income $118.0MQuarter to 1 Aug 2026: revenue $1.5B, net income $118.0MQuarter to 31 Oct 2026: revenue $1.6B, net income $38.0MQuarter to 31 Oct 2026: revenue $1.6B, net income $38.0M
29 Jan 2022RevenueNet incometallest bar $3.0B31 Oct 2026
See the numbers
Quarter toRevenueNet income
31 Oct 2026$1.6B$38.0M
1 Aug 2026$1.5B$118.0M
2 May 2026$1.4B$183.0M
31 Jan 2026$2.7B$403.0M
1 Nov 2025$1.6B$77.0M
2 Aug 2025$1.5B$64.0M
3 May 2025$1.4B$105.0M
1 Feb 2025$2.8B$453.0M
2 Nov 2024$1.6B$106.0M
3 Aug 2024$1.5B$152.0M
4 May 2024$1.4B$87.0M
3 Feb 2024$2.9B$579.0M
28 Oct 2023$1.6B$119.0M
29 Jul 2023$1.6B$99.0M
29 Apr 2023$1.4B$81.0M
28 Jan 2023$2.9B$434.0M
29 Oct 2022$1.6B$91.0M
30 Jul 2022$1.6B$120.0M
30 Apr 2022$1.4B$155.0M
29 Jan 2022$3.0B$594.0M
Fundamentals, 12 months to 31 Oct 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $7.2B $7.4B
Revenue growthRevenue of the last 12 months compared with the 12 months before. -2.2% -0.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $742.0M $699.0M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $3.61 $3.22
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 43.9% 44.1% 39.3%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 16.0% 16.4% 0.9%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 10.3% 9.5% 2.5%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. – -9.7%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $910.0M $946.0M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $318.0M $236.0M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $3.4B $3.9B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $3.0B $3.7B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. –
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 5.0 8.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.51 0.23
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 0.94 0.56
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. – 1.1
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 4.3% 1.8%

Latest = 12 months to 31 Oct 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Bath & Body WorksBBWI (this company) $3.8B5.00.51-2.2%10.3%
Sally BeautySBH $1.6B8.00.43+0.9%5.4%
Petco Health and WellnessWOOF $701.7M23.20.12-1.3%0.5%
Ulta BeautyULTA $26.3B21.82.0+11%9.3%
Titan MachineryTITN $468.1Mloss0.20-11%-2.5%
Star Group, L.P. Common Units Representing Limited Partner InterestSGU $436.7M5.00.23+7.6%4.6%

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-1.1%

$1.6B vs $1.6B (quarter ended 31 Oct 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-30%

$57.0M vs $81.0M (quarter ended 31 Oct 2026)

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$14.2

bought $0, sold $14.2

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+1.7%

466 13F filers vs 458

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

211.3M shares held by 13F filers (30 Sep 2026) of 197.8M outstanding (13 Nov 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

7.8%

15.4M shares sold short (30 Oct 2026) of 197.8M outstanding (13 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

2.5

15.4M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-12%

17.5M shares sold short in the report before, 15.4M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

61%

61% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 50%

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$150K

4 quarters

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

123

123 articles in the last 7 days; its usual week has 7 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

18×

123 articles in the last 7 days; its usual week has 7.

Price $18.66 on 20 Nov 2026, +18% over 12 months (12-month range $14.85 to $24.67)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $14.2 in the last 12 months (the 12 months before: $1.0M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 3 published in the last 12 months, -40% on the 12 months before.
Revenue per quarter. Revenue $1.6B in the latest quarter, -1.1% on a year earlier.
Capital spending per quarter. Capital spending $57.0M in the latest quarter, -30% on a year earlier.
Institutional holders (13F filers). 466 13F filers reported holding it in the latest 13F quarter, +3.1% on a year earlier.
Lobbying spend. Lobbying spend: $150K published in the last 12 months, -58% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
23 Sep 20268-K and other filingsDirector or officer change
23 Sep 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
27 May 20268-K and other filingsDirector or officer change
27 May 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
25 Feb 20268-K and other filingsDirector or officer change
25 Feb 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Jan 2026Lobbying filinglobbying engagement terminated (BT STRATEGIES, LLC)
25 Nov 2025Sharp changeClustered insider buying: clustered insider buying (4 independent filers, 4 filing(s) in 30 days, value_usd total 500K)
18 Nov 2025Sharp changeShort interest spike: short interest spike, 14.8M vs usual 7.1M (2025-10-31); 1.6x the same period a year earlier
28 Oct 2025Sharp changeShort interest spike: short interest spike, 15.3M vs usual 7.1M (2025-10-15); 1.5x the same period a year earlier
14 Oct 2025Sharp changeShort interest spike: short interest spike, 21.1M vs usual 7.1M (2025-09-30); 2.1x the same period a year earlier
30 Sep 2025Sharp changeShort interest spike: short interest spike, 20.6M vs usual 7.1M (2025-09-15); 2.3x the same period a year earlier
16 Sep 2025Sharp changeShort interest spike: short interest spike, 15.7M vs usual 7.1M (2025-08-29); 1.8x the same period a year earlier
19 May 20258-K and other filingsDirector or officer change
19 May 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Feb 20258-K and other filingsDirector or officer change
3 Feb 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
17 Jan 2025Lobbying filinglobbying engagement terminated (O'ROURKE AND ASSOCIATES, LLC)
5 Nov 2024Lobbying filingnew lobbying registration (BT STRATEGIES, LLC)
21 Oct 2024Sharp changeLobbying on a new issue: lobbying on a new issue: CHM, LAW, RRR (2024-09-30)
25 Sep 20248-K and other filingsDirector or officer change
25 Sep 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 Jul 2024Lobbying filinglobbying engagement terminated (MAGGI LAZARUS)
22 Apr 20248-K and other filingsDirector or officer change
15 Mar 20248-K and other filingsDirector or officer change
15 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
25 Jul 20238-K and other filingsDirector or officer change
25 Jul 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Apr 20238-K and other filingsDirector or officer change
6 Mar 20238-K and other filingsDirector or officer change
21 Feb 20238-K and other filingsDirector or officer change
13 Feb 20238-K and other filingsDirector or officer change
13 Feb 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
2 Nov 20228-K and other filingsDirector or officer change
17 Aug 20228-K and other filingsDirector or officer change
17 Aug 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 May 20228-K and other filingsDirector or officer change
5 May 20228-K and other filingsDirector or officer change
30 Mar 2022Lobbying filingnew lobbying registration (OGR)
28 Mar 20228-K and other filingsDirector or officer change
11 Mar 20228-K and other filingsDirector or officer change
23 Feb 20228-K and other filingsDirector or officer change
4 Feb 20228-K and other filingsDirector or officer change
4 Feb 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
11 Jan 2022Lobbying filinglobbying engagement terminated (MR. MATTHEW G. KALLNER)
Insider net buying (open market)
Month from 1 Nov 2021: -$401K published
Month from 1 Apr 2022: -$330K published
Month from 1 Jun 2022: -$690K published
Month from 1 Mar 2023: -$62K published
Month from 1 Mar 2024: -$776K published
Month from 1 Jun 2024: -$2.0M published
Month from 1 Oct 2024: $178K published
Month from 1 Nov 2025: $1.0M published
Month from 1 Oct 2026: -$14.2 published
H-1B/E-3 applications certified
Quarter from 1 Jul 2022: 2 published
Quarter from 1 Oct 2022: 4 published
Quarter from 1 Jan 2023: 1 published
Quarter from 1 Apr 2023: 1 published
Quarter from 1 Jul 2023: 1 published
Quarter from 1 Oct 2023: 1 published
Quarter from 1 Jul 2024: 1 published
Quarter from 1 Apr 2025: 1 published
Quarter from 1 Jul 2025: 2 published
Quarter from 1 Oct 2025: 2 published
Quarter from 1 Jan 2026: 1 published
Quarter from 1 Jul 2026: 2 published
Revenue per quarter
Quarter ended 30 Oct 2021: $1.7B, -45% on a year earlier; public on 4 Dec 2021
Quarter ended 29 Jan 2022: $3.0B, -37% on a year earlier; public on 19 Mar 2022
Quarter ended 30 Apr 2022: $1.4B, -52% on a year earlier; public on 3 Jun 2022
Quarter ended 30 Jul 2022: $1.6B, -51% on a year earlier; public on 3 Sep 2022
Quarter ended 29 Oct 2022: $1.6B, -4.6% on a year earlier; public on 1 Dec 2022
Quarter ended 28 Jan 2023: $2.9B, -4.6% on a year earlier; public on 18 Mar 2023
Quarter ended 29 Apr 2023: $1.4B, -3.7% on a year earlier; public on 3 Jun 2023
Quarter ended 29 Jul 2023: $1.6B, -3.6% on a year earlier; public on 2 Sep 2023
Quarter ended 28 Oct 2023: $1.6B, -2.6% on a year earlier; public on 2 Dec 2023
Quarter ended 3 Feb 2024: $2.9B, +0.8% on a year earlier; public on 23 Mar 2024
Quarter ended 4 May 2024: $1.4B, -0.9% on a year earlier; public on 5 Jun 2024
Quarter ended 3 Aug 2024: $1.5B, -2.1% on a year earlier; public on 29 Aug 2024
Quarter ended 2 Nov 2024: $1.6B, +3.1% on a year earlier; public on 27 Nov 2024
Quarter ended 1 Feb 2025: $2.8B, -4.3% on a year earlier; public on 15 Mar 2025
Quarter ended 3 May 2025: $1.4B, +2.9% on a year earlier; public on 30 May 2025
Quarter ended 2 Aug 2025: $1.5B, +1.5% on a year earlier; public on 29 Aug 2025
Quarter ended 1 Nov 2025: $1.6B, -1.0% on a year earlier; public on 21 Nov 2025
Quarter ended 31 Jan 2026: $2.7B, -2.3% on a year earlier; public on 13 Mar 2026
Quarter ended 2 May 2026: $1.4B, -3.2% on a year earlier; public on 28 May 2026
Quarter ended 1 Aug 2026: $1.5B, -2.3% on a year earlier; public on 27 Aug 2026
Quarter ended 31 Oct 2026: $1.6B, -1.1% on a year earlier; public on 20 Nov 2026
Capital spending per quarter
Quarter ended 30 Oct 2021: $63.0M, -17% on a year earlier; public on 4 Dec 2021
Quarter ended 29 Jan 2022: $29.0M, +3.6% on a year earlier; public on 19 Mar 2022
Quarter ended 30 Apr 2022: $88.0M, +35% on a year earlier; public on 3 Jun 2022
Quarter ended 30 Jul 2022: $73.0M, -35% on a year earlier; public on 3 Sep 2022
Quarter ended 29 Oct 2022: $91.0M, +44% on a year earlier; public on 1 Dec 2022
Quarter ended 28 Jan 2023: $76.0M, +162% on a year earlier; public on 18 Mar 2023
Quarter ended 29 Apr 2023: $93.0M, +5.7% on a year earlier; public on 3 Jun 2023
Quarter ended 29 Jul 2023: $85.0M, +16% on a year earlier; public on 2 Sep 2023
Quarter ended 28 Oct 2023: $72.0M, -21% on a year earlier; public on 2 Dec 2023
Quarter ended 3 Feb 2024: $48.0M, -37% on a year earlier; public on 23 Mar 2024
Quarter ended 4 May 2024: $46.0M, -51% on a year earlier; public on 5 Jun 2024
Quarter ended 3 Aug 2024: $55.0M, -35% on a year earlier; public on 29 Aug 2024
Quarter ended 2 Nov 2024: $65.0M, -9.7% on a year earlier; public on 27 Nov 2024
Quarter ended 1 Feb 2025: $60.0M, +25% on a year earlier; public on 15 Mar 2025
Quarter ended 3 May 2025: $37.0M, -20% on a year earlier; public on 30 May 2025
Quarter ended 2 Aug 2025: $56.0M, +1.8% on a year earlier; public on 29 Aug 2025
Quarter ended 1 Nov 2025: $81.0M, +25% on a year earlier; public on 21 Nov 2025
Quarter ended 31 Jan 2026: $63.0M, +5.0% on a year earlier; public on 13 Mar 2026
Quarter ended 2 May 2026: $49.0M, +32% on a year earlier; public on 28 May 2026
Quarter ended 1 Aug 2026: $49.0M, -12% on a year earlier; public on 27 Aug 2026
Quarter ended 31 Oct 2026: $57.0M, -30% on a year earlier; public on 20 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 504; public on 14 Feb 2022
31 Mar 2022 report: 457; public on 16 May 2022
30 Jun 2022 report: 456; public on 15 Aug 2022
30 Sep 2022 report: 427; public on 14 Nov 2022
31 Dec 2022 report: 469; public on 14 Feb 2023
31 Mar 2023 report: 460; public on 15 May 2023
30 Jun 2023 report: 444; public on 14 Aug 2023
30 Sep 2023 report: 431; public on 14 Nov 2023
31 Dec 2023 report: 452; public on 14 Feb 2024
31 Mar 2024 report: 479; public on 15 May 2024
30 Jun 2024 report: 490; public on 14 Aug 2024
30 Sep 2024 report: 446; public on 14 Nov 2024
31 Dec 2024 report: 466; public on 14 Feb 2025
31 Mar 2025 report: 448; public on 15 May 2025
30 Jun 2025 report: 453; public on 14 Aug 2025
30 Sep 2025 report: 452; public on 14 Nov 2025
31 Dec 2025 report: 430; public on 17 Feb 2026
31 Mar 2026 report: 454; public on 15 May 2026
30 Jun 2026 report: 458; public on 14 Aug 2026
30 Sep 2026 report: 466; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $30K published
Quarter from 1 Apr 2022: $50K published
Quarter from 1 Jul 2022: $80K published
Quarter from 1 Oct 2022: $80K published
Quarter from 1 Jan 2023: $80K published
Quarter from 1 Apr 2023: $80K published
Quarter from 1 Jul 2023: $80K published
Quarter from 1 Oct 2023: $80K published
Quarter from 1 Jan 2024: $80K published
Quarter from 1 Apr 2024: $80K published
Quarter from 1 Jul 2024: $80K published
Quarter from 1 Oct 2024: $70K published
Quarter from 1 Jan 2025: $80K published
Quarter from 1 Apr 2025: $100K published
Quarter from 1 Jul 2025: $100K published
Quarter from 1 Oct 2025: $80K published
Quarter from 1 Jan 2026: $80K published
Quarter from 1 Apr 2026: $50K published
Quarter from 1 Jul 2026: $20K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is lobbying spend reported (quarter) at $20K (30 Jun 2026), 75% below its normal reading of $80K; higher than 2% of its own history.
  • Insider net buying (open market): Insiders sold a net $14.2 in the last 12 months (the 12 months before: $1.0M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 3 published in the last 12 months, -40% on the 12 months before.
  • Revenue per quarter: Revenue $1.6B in the latest quarter, -1.1% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 45 insider trades

Last 90 days: 1 sale, $14.2; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
20 Oct 2026Sarah E NashDirectorSell1$20.56$14.2Form 4
25 Nov 2025Sarah E NashDirectorBuy10,000$15.58$156KForm 4
25 Nov 2025James Kevin SymancykDirectorBuy22,500$15.58$351KForm 4
24 Nov 2025Lucy BradyDirectorBuy3,470$14.40$50KForm 4
24 Nov 2025Francis HondalDirectorBuy3,343$15.00$50KForm 4
24 Nov 2025Steven E VoskuilDirectorBuy20,000$15.04$301KForm 4
24 Nov 2025Stephen D SteinourDirectorBuy6,700$14.86$100KForm 4
11 Oct 2024Gina BoswellChief Executive OfficerBuy6,000$29.64$178KForm 4

466 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 71 opened a position, 62 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
FMR LLC (Fidelity)26.8M13.5%$426.5M+5.7M+27%
BlackRock, Inc.20.1M10.2%$319.8M+674K+3.5%
Vanguard Portfolio Management LLC16.5M8.32%$261.9M-563K-3.3%
Vanguard Capital Management LLC9.1M4.58%$144.3M-1,2210%
State Street Corp7.2M3.64%$114.5M+53K+0.7%
Alliancebernstein L.P.5.0M2.55%$80.3M-562K-10%
AQR Capital Management LLC4.7M2.36%$74.4M-3.0M-39%
Arrowstreet Capital, Limited Partnership4.4M2.24%$70.4M+1.6M+57%
American Century Companies Inc4.1M2.07%$65.2M+9210%
GMT Capital Corp4.0M2.03%$63.8M+509K+15%

Company events

All 57 company events

In 12 months: 3 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
23 Sep 2026Director or officer change8-K
27 May 2026Director or officer change8-K
25 Feb 2026Director or officer change8-K
22 May 2025Signed a major agreementSame filing: took on new debt8-K
19 May 2025Director or officer change8-K
3 Feb 2025Director or officer change8-K
25 Sep 2024Director or officer change8-K
22 Apr 2024Director or officer change8-K

Reported lobbying spend: $20K in Q2 2026, $50K in Q1 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
31 Dec 2025EndedBT Strategies, LLCfor O'Rourke And Associates, LLC On Behalf Of Bath & Body Works, Inc.Issues relating to tax reform; including, international and domestic tax policy.TaxationFiling
31 Dec 2024EndedO'Rourke And Associates, LLCfor Bath & Body Works, Inc.Matters related to taxation of corporations including international tax regimes.TaxationFiling
3 Oct 2024NewBT Strategies, LLCfor O'Rourke And Associates, LLC On Behalf Of Bath & Body Works, Inc.Matters related to taxation of corporations including international tax regimes.TaxationFiling
3 Jun 2024EndedMaggi Lazarusfor O'Rourke And Associates, LLC (Obo Bath & Body Works, Inc. (Fka L Brands, Inc.))Issues relating to tax reform and international and domestic tax policyTaxationFiling
1 Mar 2022NewOgrfor Bath & Body Works, Inc.Issues related to chemical management and supply chain.CHMFiling
1 Oct 2021EndedMr. Matthew G. Kallnerfor L BrandsNot statedFiling
1 Oct 2021NewO'Rourke And Associates, LLCfor Bath & Body Works, Inc.Issues relating to tax reform, and international and domestic tax policy.TaxationFiling
30 Sep 2021EndedO'Rourke & Nappi, LLPfor L Brands, Inc.Issues relating to tax reform and international and domestic tax policy.TaxationFiling

The 5 newest of 633 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

25 Nov 2025confirmed

Confirmed across sources Insiders and Short interest and volume

Bath & Body Works (BBWI): had 15.3M shares sold short in the 15 Oct 2025 report, 1.5× the same report last year, while it had 4 insiders buy $500K of its shares on the open market within 30 days (4 filings). Two unrelated kinds of activity within 27 days.

  • Short interest and volume: Short interest spike, became public on 25 Oct 2025
  • Short interest and volume: Short interest spike, became public on 13 Nov 2025
  • Insiders: Clustered insider buying, became public on 25 Nov 2025
2024-10-15: 10.4M2024-10-31: 9.4M2024-11-15: 8.2M2024-11-29: 7.8M2024-12-13: 8.0M2024-12-31: 6.5M2025-01-15: 6.7M2025-01-31: 5.6M2025-02-14: 4.6M2025-02-28: 6.0M2025-03-14: 7.4M2025-03-31: 5.7M2025-04-15: 6.6M2025-04-30: 5.6M2025-05-15: 5.5M2025-05-30: 5.4M2025-06-13: 7.6M2025-06-30: 6.8M2025-07-15: 6.8M2025-07-31: 10.2M2025-08-15: 9.9M2025-08-29: 15.7M2025-09-15: 20.6M2025-09-30: 21.1M2025-10-15: 15.3M
The 15 Oct 2025 report against the 24 reports before it. this reportearliernormal: 7.1M
See the evidence (3 changes)

Short interest and volume: Short interest spike became public on 25 Oct 2025

Bath & Body Works had 15.3M shares sold short in the 15 Oct 2025 report, 1.5× the same report last year.

This period
15.3M (the 15 Oct 2025 report)
Normal report (median of 24 earlier)
7.1M
Typical spread (median absolute deviation)
1.5M
How far from its usual level
+3.8
Same report last year
10.4M
History used
1,524 days
2024-10-15: 10.4M2024-10-31: 9.4M2024-11-15: 8.2M2024-11-29: 7.8M2024-12-13: 8.0M2024-12-31: 6.5M2025-01-15: 6.7M2025-01-31: 5.6M2025-02-14: 4.6M2025-02-28: 6.0M2025-03-14: 7.4M2025-03-31: 5.7M2025-04-15: 6.6M2025-04-30: 5.6M2025-05-15: 5.5M2025-05-30: 5.4M2025-06-13: 7.6M2025-06-30: 6.8M2025-07-15: 6.8M2025-07-31: 10.2M2025-08-15: 9.9M2025-08-29: 15.7M2025-09-15: 20.6M2025-09-30: 21.1M2025-10-15: 15.3M
the 15 Oct 2025 report24 earlier reportsnormal: 7.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 13 Nov 2025

Bath & Body Works had 14.8M shares sold short in the 31 Oct 2025 report, 1.6× the same report last year.

This period
14.8M (the 31 Oct 2025 report)
Normal report (median of 24 earlier)
7.1M
Typical spread (median absolute deviation)
1.5M
How far from its usual level
+3.6
Same report last year
9.4M
History used
1,540 days
2024-10-31: 9.4M2024-11-15: 8.2M2024-11-29: 7.8M2024-12-13: 8.0M2024-12-31: 6.5M2025-01-15: 6.7M2025-01-31: 5.6M2025-02-14: 4.6M2025-02-28: 6.0M2025-03-14: 7.4M2025-03-31: 5.7M2025-04-15: 6.6M2025-04-30: 5.6M2025-05-15: 5.5M2025-05-30: 5.4M2025-06-13: 7.6M2025-06-30: 6.8M2025-07-15: 6.8M2025-07-31: 10.2M2025-08-15: 9.9M2025-08-29: 15.7M2025-09-15: 20.6M2025-09-30: 21.1M2025-10-15: 15.3M2025-10-31: 14.8M
the 31 Oct 2025 report24 earlier reportsnormal: 7.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Insiders: Clustered insider buying became public on 25 Nov 2025

Bath & Body Works had 4 insiders buy $500K of its shares on the open market within 30 days (4 filings).

Independent buyers
4
Purchase filings (Form 4, code P)
4
Total bought
$500K
Window
26 Oct 2025 to 25 Nov 2025

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 23 Sep 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 23 Sep 2026Filings record

    Director or officer change

  3. 27 May 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  4. 27 May 2026Filings record

    Director or officer change

  5. 25 Feb 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 25 Feb 2026Filings record

    Director or officer change

  7. 15 Jan 2026Lobbying record

    O'ROURKE AND ASSOCIATES, LLC ON BEHALF OF BATH & BODY WORKS, INC.: lobbying engagement terminated (BT STRATEGIES, LLC) (dated 31 Dec 2025)

  8. 26 Nov 2025Insiders record

    Nash Sarah E (director) bought 10,000 shares of BBWI ($155,800) (dated 25 Nov 2025)

  9. 26 Nov 2025Insiders record

    Symancyk James Kevin (director) bought 22,500 shares of BBWI ($350,550) (dated 25 Nov 2025)

  10. 25 Nov 2025several at once

    had 15.3M shares sold short in the 15 Oct 2025 report, 1.5× the same report last year, while it had 4 insiders buy $500K of its shares on the open market within 30 days (4 filings). Two unrelated kinds of activity within 27 days.

    See the evidence (3 changes)

    Short interest and volume: Short interest spike became public on 25 Oct 2025

    Bath & Body Works had 15.3M shares sold short in the 15 Oct 2025 report, 1.5× the same report last year.

    This period
    15.3M (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    7.1M
    Typical spread (median absolute deviation)
    1.5M
    How far from its usual level
    +3.8
    Same report last year
    10.4M
    History used
    1,524 days
    2024-10-15: 10.4M2024-10-31: 9.4M2024-11-15: 8.2M2024-11-29: 7.8M2024-12-13: 8.0M2024-12-31: 6.5M2025-01-15: 6.7M2025-01-31: 5.6M2025-02-14: 4.6M2025-02-28: 6.0M2025-03-14: 7.4M2025-03-31: 5.7M2025-04-15: 6.6M2025-04-30: 5.6M2025-05-15: 5.5M2025-05-30: 5.4M2025-06-13: 7.6M2025-06-30: 6.8M2025-07-15: 6.8M2025-07-31: 10.2M2025-08-15: 9.9M2025-08-29: 15.7M2025-09-15: 20.6M2025-09-30: 21.1M2025-10-15: 15.3M
    the 15 Oct 2025 report24 earlier reportsnormal: 7.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 13 Nov 2025

    Bath & Body Works had 14.8M shares sold short in the 31 Oct 2025 report, 1.6× the same report last year.

    This period
    14.8M (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    7.1M
    Typical spread (median absolute deviation)
    1.5M
    How far from its usual level
    +3.6
    Same report last year
    9.4M
    History used
    1,540 days
    2024-10-31: 9.4M2024-11-15: 8.2M2024-11-29: 7.8M2024-12-13: 8.0M2024-12-31: 6.5M2025-01-15: 6.7M2025-01-31: 5.6M2025-02-14: 4.6M2025-02-28: 6.0M2025-03-14: 7.4M2025-03-31: 5.7M2025-04-15: 6.6M2025-04-30: 5.6M2025-05-15: 5.5M2025-05-30: 5.4M2025-06-13: 7.6M2025-06-30: 6.8M2025-07-15: 6.8M2025-07-31: 10.2M2025-08-15: 9.9M2025-08-29: 15.7M2025-09-15: 20.6M2025-09-30: 21.1M2025-10-15: 15.3M2025-10-31: 14.8M
    the 31 Oct 2025 report24 earlier reportsnormal: 7.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Insiders: Clustered insider buying became public on 25 Nov 2025

    Bath & Body Works had 4 insiders buy $500K of its shares on the open market within 30 days (4 filings).

    Independent buyers
    4
    Purchase filings (Form 4, code P)
    4
    Total bought
    $500K
    Window
    26 Oct 2025 to 25 Nov 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  11. 25 Nov 2025Insiders change

    had 4 insiders buy $500K of its shares on the open market within 30 days (4 filings).

    Who bought: Steinour Stephen D, Voskuil Steven E, Hondal Francis, Brady Lucy.

    See the evidence (4 source records)
    Independent buyers
    4
    Purchase filings (Form 4, code P)
    4
    Total bought
    $500K
    Window
    26 Oct 2025 to 25 Nov 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  12. 25 Nov 2025Insiders record

    Brady Lucy (director) bought 3,470 shares of BBWI ($49,962) (dated 24 Nov 2025)

  13. 25 Nov 2025Insiders record

    Hondal Francis (director) bought 3,343 shares of BBWI ($50,145) (dated 24 Nov 2025)

  14. 25 Nov 2025Insiders record

    Voskuil Steven E (director) bought 20,000 shares of BBWI ($300,800) (dated 24 Nov 2025)

  15. 25 Nov 2025Insiders record

    STEINOUR STEPHEN D (director) bought 6,700 shares of BBWI ($99,562) (dated 24 Nov 2025)

  16. 13 Nov 2025Short interest and volume change

    had 14.8M shares sold short in the 31 Oct 2025 report, 1.6× the same report last year.

    Same report last year: 9.4M; its normal report is 7.1M.

    See the evidence
    This period
    14.8M (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    7.1M
    Typical spread (median absolute deviation)
    1.5M
    How far from its usual level
    +3.6
    Same report last year
    9.4M
    History used
    1,540 days
    2024-10-31: 9.4M2024-11-15: 8.2M2024-11-29: 7.8M2024-12-13: 8.0M2024-12-31: 6.5M2025-01-15: 6.7M2025-01-31: 5.6M2025-02-14: 4.6M2025-02-28: 6.0M2025-03-14: 7.4M2025-03-31: 5.7M2025-04-15: 6.6M2025-04-30: 5.6M2025-05-15: 5.5M2025-05-30: 5.4M2025-06-13: 7.6M2025-06-30: 6.8M2025-07-15: 6.8M2025-07-31: 10.2M2025-08-15: 9.9M2025-08-29: 15.7M2025-09-15: 20.6M2025-09-30: 21.1M2025-10-15: 15.3M2025-10-31: 14.8M
    the 31 Oct 2025 report24 earlier reportsnormal: 7.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 25 Oct 2025Short interest and volume change

    had 15.3M shares sold short in the 15 Oct 2025 report, 1.5× the same report last year.

    Same report last year: 10.4M; its normal report is 7.1M.

    See the evidence
    This period
    15.3M (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    7.1M
    Typical spread (median absolute deviation)
    1.5M
    How far from its usual level
    +3.8
    Same report last year
    10.4M
    History used
    1,524 days
    2024-10-15: 10.4M2024-10-31: 9.4M2024-11-15: 8.2M2024-11-29: 7.8M2024-12-13: 8.0M2024-12-31: 6.5M2025-01-15: 6.7M2025-01-31: 5.6M2025-02-14: 4.6M2025-02-28: 6.0M2025-03-14: 7.4M2025-03-31: 5.7M2025-04-15: 6.6M2025-04-30: 5.6M2025-05-15: 5.5M2025-05-30: 5.4M2025-06-13: 7.6M2025-06-30: 6.8M2025-07-15: 6.8M2025-07-31: 10.2M2025-08-15: 9.9M2025-08-29: 15.7M2025-09-15: 20.6M2025-09-30: 21.1M2025-10-15: 15.3M
    the 15 Oct 2025 report24 earlier reportsnormal: 7.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 10 Oct 2025Short interest and volume change

    had 21.1M shares sold short in the 30 Sep 2025 report, 2.1× the same report last year.

    Same report last year: 10.0M; its normal report is 7.1M.

    See the evidence
    This period
    21.1M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    7.1M
    Typical spread (median absolute deviation)
    1.5M
    How far from its usual level
    +6.5
    Same report last year
    10.0M
    History used
    1,509 days
    2024-09-30: 10.0M2024-10-15: 10.4M2024-10-31: 9.4M2024-11-15: 8.2M2024-11-29: 7.8M2024-12-13: 8.0M2024-12-31: 6.5M2025-01-15: 6.7M2025-01-31: 5.6M2025-02-14: 4.6M2025-02-28: 6.0M2025-03-14: 7.4M2025-03-31: 5.7M2025-04-15: 6.6M2025-04-30: 5.6M2025-05-15: 5.5M2025-05-30: 5.4M2025-06-13: 7.6M2025-06-30: 6.8M2025-07-15: 6.8M2025-07-31: 10.2M2025-08-15: 9.9M2025-08-29: 15.7M2025-09-15: 20.6M2025-09-30: 21.1M
    the 30 Sep 2025 report24 earlier reportsnormal: 7.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 25 Sep 2025Short interest and volume change

    had 20.6M shares sold short in the 15 Sep 2025 report, 2.3× the same report last year.

    Same report last year: 8.9M; its normal report is 7.1M.

    See the evidence
    This period
    20.6M (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    7.1M
    Typical spread (median absolute deviation)
    1.5M
    How far from its usual level
    +6.3
    Same report last year
    8.9M
    History used
    1,494 days
    2024-09-13: 8.9M2024-09-30: 10.0M2024-10-15: 10.4M2024-10-31: 9.4M2024-11-15: 8.2M2024-11-29: 7.8M2024-12-13: 8.0M2024-12-31: 6.5M2025-01-15: 6.7M2025-01-31: 5.6M2025-02-14: 4.6M2025-02-28: 6.0M2025-03-14: 7.4M2025-03-31: 5.7M2025-04-15: 6.6M2025-04-30: 5.6M2025-05-15: 5.5M2025-05-30: 5.4M2025-06-13: 7.6M2025-06-30: 6.8M2025-07-15: 6.8M2025-07-31: 10.2M2025-08-15: 9.9M2025-08-29: 15.7M2025-09-15: 20.6M
    the 15 Sep 2025 report24 earlier reportsnormal: 7.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 11 Sep 2025Short interest and volume change

    had 15.7M shares sold short in the 29 Aug 2025 report, 1.8× the same report last year.

    Same report last year: 8.8M; its normal report is 7.1M.

    See the evidence
    This period
    15.7M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    7.1M
    Typical spread (median absolute deviation)
    1.5M
    How far from its usual level
    +4.0
    Same report last year
    8.8M
    History used
    1,477 days
    2024-08-30: 8.8M2024-09-13: 8.9M2024-09-30: 10.0M2024-10-15: 10.4M2024-10-31: 9.4M2024-11-15: 8.2M2024-11-29: 7.8M2024-12-13: 8.0M2024-12-31: 6.5M2025-01-15: 6.7M2025-01-31: 5.6M2025-02-14: 4.6M2025-02-28: 6.0M2025-03-14: 7.4M2025-03-31: 5.7M2025-04-15: 6.6M2025-04-30: 5.6M2025-05-15: 5.5M2025-05-30: 5.4M2025-06-13: 7.6M2025-06-30: 6.8M2025-07-15: 6.8M2025-07-31: 10.2M2025-08-15: 9.9M2025-08-29: 15.7M
    the 29 Aug 2025 report24 earlier reportsnormal: 7.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 19 May 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  22. 19 May 2025Filings record

    Director or officer change

  23. 3 Feb 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  24. 3 Feb 2025Filings record

    Director or officer change

  25. 17 Jan 2025Lobbying record

    BATH & BODY WORKS, INC.: lobbying engagement terminated (O'ROURKE AND ASSOCIATES, LLC) (dated 31 Dec 2024)

  26. 5 Nov 2024Lobbying record

    O'ROURKE AND ASSOCIATES, LLC ON BEHALF OF BATH & BODY WORKS, INC.: new lobbying registration (BT STRATEGIES, LLC) (dated 3 Oct 2024)

  27. 21 Oct 2024Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['CHM', 'LAW', 'RRR']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    6275058
  28. 12 Oct 2024Insiders record

    Boswell Gina (Chief Executive Officer) bought 6,000 shares of BBWI ($177,840) (dated 11 Oct 2024)

  29. 25 Sep 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  30. 25 Sep 2024Filings record

    Director or officer change

  31. 21 Jul 2024Lobbying record

    O'ROURKE AND ASSOCIATES, LLC (OBO BATH & BODY WORKS, INC. (FKA L BRANDS, INC.)): lobbying engagement terminated (MAGGI LAZARUS) (dated 3 Jun 2024)

  32. 22 Apr 2024Filings record

    Director or officer change

  33. 15 Mar 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  34. 15 Mar 2024Filings record

    Director or officer change

  35. 25 Jul 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 25 Jul 2023Filings record

    Director or officer change

  37. 6 Apr 2023Filings record

    Director or officer change

  38. 6 Mar 2023Filings record

    Director or officer change

  39. 21 Feb 2023Filings record

    Director or officer change

  40. 13 Feb 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

Showing the newest 40 of 114 entries; narrow the window or the kind of data to see older ones.

Not listed: 197 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000701985
Ticker
BBWI
Domain
bbwinc.com
Employer name
bath and body works direct, Bath & Body Works Brand Management, Inc., Bath & Body Works, LLC, BATH & BODY WORKS LOGISTICS SERVICES, LLC (4 unverified)
Hq location
OH|COLUMBUS|43230 (1 unverified)
Lobbying client
bath and body works, l brands, l brands inc formerly known as limited brands, limited brands and 2 more
Name
Bath & Body Works Brand Management, Inc, Bath & Body Works Direct, Inc, Bath & Body Works, Inc., beautyAvenues, LLC and 11 more
Wikipedia
Bath & Body Works, Bath & Body Works, Inc.
  • DOL H-1B labor condition applications and PERM certifications119 data points2 Mar 2020 to 1 Jun 2026
  • Federal lobbying disclosures (LDA)26 records, 278 data points30 Jun 1999 to 30 Sep 2026
  • SEC Form 13F institutional holdings10 records, 198 data points30 Jun 2021 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)208 records5 Feb 2016 to 19 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1238 data points3 Feb 2007 to 13 Nov 2026
  • SEC Form 4 insider transactions45 records, 148 data points25 Mar 2016 to 20 Oct 2026
  • FINRA short interest (twice monthly)374 data points13 Aug 2021 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2666 data points3 Aug 2021 to 20 Nov 2026
  • Wikipedia pageviews11 data points11 Nov 2026 to 21 Nov 2026